The effect of remifentanil on the emergence characteristics of children undergoing FBO for bronchoalveolar lavage with sevoflurane anaesthesia

European Journal of Anaesthesiology

Volumn 26, Issue 4, 2009, Pages 338-342

  Ozturk, Tulun ^a   Erbuyun, Koray ^a   Keles, Gonul Tezcan ^a   Ozer, Mert ^a   Yuksel, Hasan ^a   Tok, Demet ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Agitation; Anaesthetics; Children; Complications; Cough; Inhalation; Intravenous; Midazolam; Premedication; Remifentanil; Sevofluran

Indexed keywords

ATROPINE; LIDOCAINE; MIDAZOLAM; REMIFENTANIL; SEVOFLURANE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

AGITATION; ANESTHETIC RECOVERY; ARTICLE; CHILD; CLINICAL ARTICLE; COUGHING; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LUNG LAVAGE; MALE; MUSCLE RIGIDITY; PEDIATRIC ANESTHESIA; PRESCHOOL CHILD; SEDATION; BRONCHOSCOPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBER OPTICS; INSTRUMENTATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TIME; TREATMENT OUTCOME;

ANALGESICS, OPIOID; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; COUGH; FEMALE; FIBER OPTIC TECHNOLOGY; HUMANS; MALE; METHYL ETHERS; PIPERIDINES; PSYCHOMOTOR AGITATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 68849086744     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32831de50d     Document Type: Article

References (19)

1. Irwin RS. Complications of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:54S-58S.
2. Hohlrieder M, Tiefenthaler W, Klaus H, et al. Effect of total intravenous anaesthesia and balanced anaesthesia on the frequency of coughing during emergence from the anaesthesia. Br J Anaesth 2007; 99:587-591.
3. Guler G, Akin A, Tosun Z, et al. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Pediatric Anesthesia 2005; 15:762-766.
4. Schwarz Y, Greif J, Lurie O, et al. Dextromethorphan premedication reduces midazolam requirement: objective and subjective parameters in peribronchoscopy. Respiration 2007; 74:314-319.
5. Berkenbosch JW, Graff GR, Stark JM, et al. Use of remifentanil-propofol mixture for pediatric flexible fiberoptic bronchoscopy sedation. Paediatr Anaesth 2004; 14:941-946.
6. Weldon VC, Bell M, Craddack T. The effect of caudal analgesia on emergence agitation in children after sevoflurane versus halothane anesthesia. Anesth Analg 2004; 98:321-326.
7. Voepel Lewis T, Malvia S, Tait AR. A prospective cohort study of emergence agitation in the pediatric postanaesthesia care unit. Anesth Analg 2003; 96:1625-1630.
8. Cole JW, Murray DJ, McAlister JD, et al. Emergence behaviour in children: defining the incidence of excitement and agitation following anaesthesia. Paediatr Anaesth 2002; 12:442-447.
9. Shajar MA, Thompson JP, Hall AP, et al. Effect of a remifentanil bolus dose on the cardiovascular response to emergence from anaesthesia and tracheal extubation. Br J Anaesth 1999; 83:654-656.
10. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus of remifentanil during bolus administration reported alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiol 1996; 84:821-833.
11. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiol 1993; 79:893-903.
12. Ross AK, Davis PJ, deL Dear G, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 2001; 93:1393-1401.
13. Joshi GP, Warner DS, Twersky RS, Fleisher LA. A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study. J Clin Anesth 2002; 14:494-499.
14. Schüttler J, Albrecht S, Breivik H, et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997; 52:307-317.
15. Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 1999; 89:7-14.
16. Weber F, Fussel U, Gruber M, Hobbhahn J. The use of remifentanil for intubation in paediatric patients during sevoflurane anaesthesia guided by Bispectral Index (BIS) monitoring. Anaesthesia 2003; 58:749-755.
17. Denman WT, Swanson EL, Rosow D, et al. Pediatric evaluation of the bispectral index (BIS) monitor and correlation of the BIS with endtidal sevoflurane concentration in infants and children. Anesth Analg 2000; 90:872-877.
18. Constant I, Leport Y, Richard P, et al. Agitation and changes of Bispectral Index and electroencephalographic-derived variables during sevoflurane induction in children: clonidine premedication reduces agitation compared with midazolam. Br J Anaesth 2004; 92:504-511.
19. Min SK, Kwak YL, Park SY, et al. The optimal dose of remifentanil for intubation during sevoflurane induction without neuromuscular blockade in children. Anaesthesia 2007; 62:446-450.